AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2012
Sep 17, 2012
35124_dirs_2012-09-17_51df0de8-dd01-4836-aede-2a7099e40f64.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-09-14
Reporting Person: CHURCH JEFFREY WAYNE (SVP Corp Bus Strategy/IR)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-14 | Celsion Corporation Common Stock | P | 2000 | $4.9295 | Acquired | 18787 | Direct |
Footnotes
F1: The shares of common stock were purchased by the officer on the open market.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23